Reliance Steel & Aluminum Co. ‘s ( RS ) third-quarter 2012 earnings per share of $1.30 outperformed the Zacks Consensus Estimate of $1.20 and surpassed the year-ago earnings of
Regeneron Pharmaceuticals Inc. ‘s ( REGN ) third quarter 2012 earnings (excluding special items but including stock-based compensation) of $1.70 per share breezed past the Zacks